Screener
Maravai LifeSciences Holdings, Inc. MRVI Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 34.9%+4.4pp | 29.3%-8.0pp | 18.3%-23.5pp | 21.1%-25.2pp | 30.5%-15.3pp | |
| Operating margin | -56.1%+88.9pp | -82.2%+27.8pp | -115.9%-25.0pp | -100.9%-26.8pp | -145%-125pp | |
| Net margin | -37.1%+50.5pp | -51.1%+16.2pp | -70.4%-14.5pp | -62.9%+18.4pp | -87.6%-38.7pp | |
| Returns | ||||||
| Return on equity | -32.9%+22.1pp | -40.8%+4.9pp | -48.6%-9.6pp | -41%+11.1pp | -55%-26.8pp | |
| Return on invested capital | -34.5%+46.1pp | -51.1%+19.5pp | -58.2%-1.6pp | -55.7%-32.4pp | -80.7%-75.1pp | |
| Efficiency | ||||||
| Asset turnover | 0.3×+0.1× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Liquidity | ||||||
| Current ratio | 4.1×-1.1× | 5.9×-0.1× | 6.6×-0.9× | 5.3×-5.4× | 5.2×-4.8× | |
| Leverage | ||||||
| Debt-to-equity | 0.9×-0.5× | 1.3×+0.2× | 1.7×+0.6× | 1.5×-0.1× | 1.4×+0.1× | |
| Per Share | ||||||
| Book value per share | $1.38-25.0% | $1.44-31.1% | $1.47-37.6% | $1.70-30.4% | $1.84-42.4% | |
| Valuation | ||||||
| Market capitalization | $918.96M+210% | $414.26M+30.5% | $471.32M-39.0% | $415.23M-80.7% | $321.07M-82.2% | |
| Price / sales | 4.4×+3.1× | 2×+0.7× | 2.5×-0.4× | 2.2×-5.6× | 1.5×-5.1× | |
| Price / book | 4.5×+3.4× | 2×+0.9× | 2.2×-0.2× | 1.7×-4.5× | 1.2×-2.9× |
FAQ
- What are Maravai LifeSciences Holdings, Inc.'s profit margins?
- Maravai LifeSciences Holdings, Inc. (MRVI) runs a 34.9% gross margin and a -56.1% operating margin, with a -37.1% net margin.
- Where do Maravai LifeSciences Holdings, Inc.'s ratios come from?
- Every ratio is computed from Maravai LifeSciences Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
